Deadline: 1 December 2014
The United States Agency for International Development (USAID) invites organizations willing to collaborate with the USAID Global Health Bureau, Ebola Response Team, and Global Development Lab to submit an expression of interest for its first Addendum Personal Protective Equipment and Infection Treatment and Control. Interested organizations should describe their idea/approach, highlight their group’s value to the partnership and discuss the potential of their idea to be rapidly deployed and have a substantial impact on the Ebola response. Grant will range between $100,000 to $ 1 million.
- Strengthen Healthcare capacities – Approaches to
enhance the protective equipment, care setting and tools used in the
field to empower and protect healthcare workers.
- Personal Protective Equipment (PPE)
- Care Setting
- Health Care Worker Tools
- Care-Seeking – Approaches that ensure communities receive and respond to timely, accurate, and actionable information about Ebola prevention and treatment.
Selected organizations or consortia will be invited, individually or in combination, to discuss their proposals with USAID and its partners, which may result in one or more applicants being invited to submit concept notes.
USAID is seeking for resource partners with following capabilities (but not limited to)
- Ability to rapidly prototype and produce manufacture-ready products
- Ability to deploy solutions in contexts worldwide, particularly West Africa
- Ability to produce or improve any existing technologies currently in use
- Capacity and willingness to partner to test identified solutions
- Applicants can be public, private, for-profit, and non-profit organizations, as well as institutions of higher education, public international organizations, non-governmental organizations, US and non-US government organizations, and international donor organizations.
- EOI must demonstrate innovation, low-cost and ability to be scaled rapidly, and strong likelihood of achieving a substantial impact.
- EIO must clearly demonstrate solutions that can be deployed and have an impact in the near-term (2-3 months of initial investment) or longer-term (within a year of initial investment), and improve the response to the current Ebola epidemic as well as future outbreaks.
- Expression of interest must be in English, submitted electronically using the link to application platform. It can be up to 3 pages (12 point font), contain header with respondent name/group and contact information, response title and BAA addendum name/number.
- Organizations must ensure that any submissions under the Addendum are free of any third party proprietary data rights that would impact the license granted to USAID herein.
- Partnership expectations and value
For more information, please visit EbolaGrandChallenge.